title: High compared with standard dose lipase pancreatic supplement.
abstract: Cotazym-S-Forte, a new pancreatic supplement containing 10,000 BP units of lipase activity per capsule, was compared with a standard dose pancreatin supplement (Pancrease) with 5000 BP units lipase activity in a randomised crossover trial. The number of capsules of Cotazym-S-Forte administered was half the usual number of Pancrease capsules and was associated with the same degree of fat absorption as Pancrease.
authors.affiliation: Professorial Department of Thoracic Medicine, Royal Children's Hospital, Melbourne, Australia.
authors.forename: P J
authors.initials: PJ
authors.lastname: Robinson
authors.forename: A
authors.initials: A
authors.lastname: Olinsky
authors.forename: A L
authors.initials: AL
authors.lastname: Smith
authors.forename: S B
authors.initials: SB
authors.lastname: Chitravanshi
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000378:metabolism; D003692:Delayed-Action Preparations; D004041:Dietary Fats / Q000378:metabolism; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007223:Infant; D008049:Lipase / Q000008:administration & dosage*; D008297:Male; D011897:Random Allocation
chemical_list: D003692:Delayed-Action Preparations; D004041:Dietary Fats; D008049:Lipase